Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.97 USD | -0.66% |
|
+0.25% | -9.78% |
06-18 | Stifel Initiates Celldex Therapeutics at Buy Rating With $58 Price Target | MT |
06-11 | Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing | MT |